Chinese – ArcticBio

Mon. Jan 12th, 2026

Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans

December 10, 2025 admin

A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to advance its lead KRAS inhibitor into phase 3…

Chinese CRO

Chinese CRO ChemPartner gets ready to debut new Boston research facility

August 26, 2025 admin

Chinese contract research and manufacturing outfit ChemPartner is building out its U.S. footprint in the heart of the bustling Boston biotech scene. The company’s new Boston Center of Excellence is…

Category: Chinese

Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans

Chinese CRO ChemPartner gets ready to debut new Boston research facility

You missed

Reinforced Optical Cages Ensure Drift-Free Molecule Imaging

iPS-Derived 3D Model Advances Brain Barrier Research

Advancing Neonatal Brain Prognosis with Diffusion Kurtosis

ctDNA-Guided Therapy Advances Muscle-Invasive Bladder Cancer